Luo, J., Makhnin, A., Tobi, Y., Ahn, L., Hayes, S. A., Iqbal, A., . . . Yu, H. A. (2021). Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor. JCO Precis Oncol.
Citação norma ChicagoLuo, Jia, et al. "Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor." JCO Precis Oncol 2021.
MLA CitationLuo, Jia, et al. "Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor." JCO Precis Oncol 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.